PROFUSA, INC. Current Federal Tax Expense (Benefit)
PROFUSA, INC. (PFSA) reported Current Federal Tax Expense (Benefit) of $94.17 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-31.
Financial Statements › Expense Statement › Income Tax
us-gaap:CurrentFederalTaxExpenseBenefit · last filed 2025-03-31
- PROFUSA, INC. current federal tax expense (benefit) for fiscal 2024 was $94.17K, a 80.38% decline from fiscal 2023.
- PROFUSA, INC. current federal tax expense (benefit) for fiscal 2023 was $480.07K, a 3.85% increase from fiscal 2022.
- PROFUSA, INC. current federal tax expense (benefit) for fiscal 2022 was $462.27K.
| Period end | Current Federal Tax Expense (Benefit) 12 month |
|---|---|
| 2024-12-31 | $94.17K 10-K · filed 2025-03-31 |
| 2023-12-31 | $480.07K 10-K · filed 2025-03-31 |
| 2022-12-31 | $462.27K 10-K · filed 2024-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |